Volume 19, Number 10—October 2013
Letter
Human Infection with Eurasian Avian-like Influenza A(H1N1) Virus, China
Table
Age group, y | Antigen | Increase ≥4, %‡ | Geometric mean titer |
%Titer ≥40 |
%Titer ≥160 |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Before vac. | After vac. | Before vac. | After vac. | Before vac. | After vac. | ||||||
Children, n = 25 | A/California/7/2009 | 60.0 | 21.1 | 121.3 | 44.0 | 84.0 | 16.0 | 60.0 | |||
3–5 | HB/1250/12 | 24.0 | 12.8 | 25.7 | 28.0 | 56.0 | 0 | 24.0 | |||
Adults, n = 30 | A/California/7/2009 | 70.0 | 14.8 | 156.3 | 26.7 | 76.7 | 0 | 60.0 | |||
18–59 | HB/1250/12 | 6.7 | 8.1 | 31.7 | 6.7 | 56.7 | 0 | 23.3 | |||
Elderly adults, n = 30 | A/California/7/2009 | 46.7 | 10.5 | 52.8 | 10.0 | 53.3 | 0 | 30.0 | |||
>60 | HB/1250/12 | 26.7 | 5.7 | 11.5 | 0 | 26.7 | 0 | 6.7 |
*Vac., vaccination.
†All children received 2 doses of vaccine with an interval of 1 month. The composition of the trivalent vaccine were A/Christchurch/16/2010(NIB-74xp) (A/California/7/2009-like), A/Victoria/361/2011 (H3N2)IVR-165, and B/Hubei-Wujiagang/158/2009. Serum samples were obtained from vaccine recipients living in northern (children) and southern (adults and elderly adults) China.
‡Increase in antibody titer.
1These authors contributed equally to this article.
Page created: September 17, 2013
Page updated: September 17, 2013
Page reviewed: September 17, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.